Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6555581 | KING PHARMS | Levothyroxine compositions and methods |
Feb, 2022
(11 months ago) | |
US7067148 | KING PHARMS | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
Feb, 2022
(11 months ago) | |
US7101569 | KING PHARMS | Methods of administering levothyroxine pharmaceutical compositions |
Oct, 2023
(7 months from now) |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 25 May, 2001
Treatment: Method of use of administering levothyroxine
Dosage: TABLET;ORAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7122566 | KING PHARMS | Metaxalone products, method of manufacture, and method of use |
Feb, 2026
(3 years from now) |
Drugs and Companies using METAXALONE ingredient
Market Authorisation Date: 30 August, 2002
Treatment: Treatment of musculoskeletal conditions
Dosage: TABLET;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic